MG
MDT icon

Marex Group’s Medtronic MDT Stock Holding History

Marex Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Buy
8,948
+3,108
+53% +$251K ﹤0.01% 601
2026
Q1 		$506K Buy
5,840
+1,667
+40% +$160K ﹤0.01% 619
2025
Q4 		$401K Sell
4,173
-83,279
-95% -$8.09M ﹤0.01% 626
2025
Q3 		$8.33M Buy
87,452
+83,819
+2,307% +$7.71M 0.06% 154
2025
Q2 		$317K Sell
3,633
-5,388
-60% -$457K ﹤0.01% 439
2025
Q1 		$811K Buy
9,021
+6,032
+202% +$540K 0.02% 261
2024
Q4 		$239K Sell
2,989
-62
-2% -$5.37K ﹤0.01% 500
2024
Q3 		$275K Sell
3,051
-75,193
-96% -$6.33M 0.01% 397
2024
Q2 		$6.16M Buy
78,244
+73,823
+1,670% +$6.05M 0.17% 84
2024
Q1 		$385K Buy
4,421
+480
+12% +$41K 0.01% 294
2023
Q4 		$325K Buy
3,941
+398
+11% +$30.3K 0.01% 375
2023
Q3 		$278K Buy
3,543
+965
+37% +$80.8K 0.04% 162
2023
Q2 		$227K Sell
2,578
-568
-18% -$48.9K 0.04% 188
2023
Q1 		$254K Buy
+3,146
New +$256K 0.03% 216

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Marex Group's MDT Position: Q2 2026 in Review

Marex Group increased its Medtronic (MDT) stake by 53% in Q2 2026, buying an estimated $251K and bringing the position to 8,948 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Marex Group first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $8.33M in Q3 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Marex Group held 8,948 shares of Medtronic worth $700K as of Q2 2026.
  • Marex Group bought 3,108 Medtronic shares in Q2 2026, an estimated $251K.
  • Medtronic made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #601 holding.
  • Marex Group first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Marex Group's Medtronic position peaked at $8.33M in Q3 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.